Clinical Trial Update: Prolonged Exposure for Post Traumatic Stress Disorder (PTSD) With/Without Yohimbine [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating prolonged exposure therapy for PTSD with or without yohimbine; study completed with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-traumatic Stress Disorder

Drugs mentioned

• yohimbine (yohimbine)

Snippet

Sponsor: VA Office of Research and Development | Conditions: Post-Traumatic Stress Disorder | Phase 2 | Status: COMPLETED | Results posted: 2017-02-24